Preparation of a biomimetic polyphosphorylcholine monolithic column for immobilized artificial membrane chromatography.

Preparation of a biomimetic polyphosphorylcholine monolithic column for immobilized artificial membrane chromatography.
复制标题

DOI:
10.1016/j.chroma.2015.06.056
复制
发表时间:
2015-08
期刊:
Journal of chromatography. A
影响因子:
--
通讯作者:
Xianglong Zhao;Weijia Chen;Zhengyin Zhou;Qiqin Wang;Zhenghua Liu;R. Moaddel;Zhengjin Jiang
Xianglong Zhao;Weijia Chen;Zhengyin Zhou;Qiqin Wang;Zhenghua Liu;R. Moaddel;Zhengjin Jiang
中科院分区:
其他
文献类型:
--
作者:
Xianglong Zhao;Weijia Chen;Zhengyin Zhou;Qiqin Wang;Zhenghua Liu;R. Moaddel;Zhengjin Jiang

文献摘要

相似文献

The present work aims to prepare a novel phosphatidylcholine functionalized monolithic stationary phase byin situco-polymerization of 12-methacryloyl dodecylphosphocholine (MDPC) and ethylene dimethacrylate (EDMA) for immobilized artificial membrane chromatography. Scanning electron microscopy, energy dispersive X-ray spectroscopy, FT-IR spectroscopy, pore size distribution analysis, ζ-potential analysis and micro-HPLC were used to evaluate the monolithic structure and physicochemical properties. Satisfactory morphology, high mechanical stability, good permeability and chromatographic performance were obtained on the optimized monolithic columns. A typical reverse-phase retention mechanism was observed over a wide range of organic solvent content (acetonitrile< 80%). The optimized poly(MDPC-co-EDMA) monolith exhibited good selectivity for proteins and basic drugs. Good correlation was observed between the retention on commercial IAM column (IAM.PC.DD2) and poly(MDPC-co-EDMA) monolith. This novel poly(MDPC-co-EDMA) monolith exhibited good potential for studying the drug-membrane interaction.